Mesenchymal stem cell
Intravenous (IV) Injection
Organization | University
Mesenchymal stem cells derived from allogeneic, bone marrow.
To assess the safety and feasibility of mesenchymal stem cells therapy in patients with transplant related bronchiolitis obliteran syndrome (BOS)
This drug has no clinical trials actively recruiting patients at this time.